Literature DB >> 19308813

t(3;9;22) 3-way chromosome translocation in chronic myeloid leukemia is associated with poor prognosis.

Jiahuai Tan1, Shundong Cang, Karen Seiter, Suneeta Primanneni, Nasir Ahmed, Thomas Mathews, Delong Liu.   

Abstract

Chronic myelogenous leukemia (CML) is genetically characterized by the reciprocal translocation of chromosome 9 and 22. Around 5-8% of CML develop complex variant Ph translocations involving one or more chromosomal regions besides 9 and 22. Chromosome 3 is not frequently involved in complex translocations in CML. We report in this study a case of CML displaying a t(3;9;22) 3-way translocation. A review of the literature appears to indicate that CML patients with this translocation tend to have an aggressive course and poor outcome. Additional 3-way chromosome translocations associated with CML are also reviewed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19308813     DOI: 10.1080/07357900802653498

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  4 in total

1.  Management of chronic myeloid leukemia presenting with isolated thrombocytosis and complex Philadelphia chromosome: A case report.

Authors:  Lu Gao; Ming-Qiang Ren; Zu-Guo Tian; Zhi-Yuan Peng; Genghui Shi; Zhong Yuan
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

2.  Co-existence of isodicentric Ph chromosomes and the three-way Ph chromosome variant t(3;9;22)(p21;q34;q11) in a rare case of chronic myeloid leukemia.

Authors:  Qian Li; Xiao-Ji Lin; Hui Chen; Jian Gong; Zhen Li; Xiang-Nan Chen
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

3.  Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene.

Authors:  Masaya Okada; Atsushi Satake; Katsuji Kaida; Kyoko Taniguchi; Satoshi Yoshihara; Kazuhiro Ikegame; Hiroya Tamaki; Toshihiro Soma; Yoshihiro Fujimori; Hiroyasu Ogawa
Journal:  Int J Hematol       Date:  2011-02-01       Impact factor: 2.490

4.  Investigating critical genes and gene interaction networks that mediate cyclophosphamide sensitivity in chronic myelogenous leukemia.

Authors:  Xiao He; Yuying Deng; Wei Yue
Journal:  Mol Med Rep       Date:  2017-05-26       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.